Kenichi Nakamura

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Kazumasa Fujitani, Han‐Kwang Yang, Junki Mizusawa et al. · The Lancet Oncology · 2016 · 688 citations

Single Non-curable Factor, Surgical Oncology, Gastrointestinal Oncology +8

A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)

Kenichi Nakamura, Hisashi Saji, R. Nakajima et al. · Japanese Journal of Clinical Oncology · 2009 · 525 citations · Full text

Human Microbiome <i>Fusobacterium Nucleatum</i> in Esophageal Cancer Tissue Is Associated with Prognosis

Kensuke Yamamura, Yoshifumi Baba, Shigeki Nakagawa et al. · Clinical Cancer Research · 2016 · 440 citations · Full text

Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection

Daisuke Kuroda, Hiroshi Sawayama, Junji Kurashige et al. · Gastric Cancer · 2017 · 344 citations · Full text

Nutrition, Surgical Oncology, Body Composition +12

Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)

Kenichi Nakamura, Ken Kato, Hiroyasu Igaki et al. · Japanese Journal of Clinical Oncology · 2013 · 296 citations

Surgical Oncology, Esophageal Cancer, Gastroenterology +16